| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Leila Hosseinzadeh Anvar, Seyyed Ebrahim Moosavi, Saeid Charsouei, Narges Zeinalzadeh, Masoud Nikanfar, Ali Ahmadalipou. Association Between the Endocannabinoid System-Related Gene Variants and Epilepsy. Molecular neurobiology. 2024-04-05. PMID:38578355. |
association between the endocannabinoid system-related gene variants and epilepsy. |
2024-04-05 |
2024-04-07 |
Not clear |
| Mathias C Eymery, Ahcène Boumendjel, Andrew A McCarthy, Jens Hausman. Linking the Autotaxin-LPA Axis to Medicinal Cannabis and the Endocannabinoid System. International journal of molecular sciences. vol 25. issue 6. 2024-03-28. PMID:38542186. |
over the past few decades, many current uses for cannabinoids have been described, ranging from controlling epilepsy to neuropathic pain and anxiety treatment. |
2024-03-28 |
2024-03-30 |
Not clear |
| Yasaman Javadzadeh, Alexandra Santos, Mark S Aquilino, Shanthini Mylvaganam, Karolina Urban, Peter L Carle. Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ Cells. vol 13. issue 6. 2024-03-27. PMID:38534310. |
cannabidiol exerts anticonvulsant effects alone and in combination with Δ cannabinoids have shown potential in drug-resistant epilepsy treatment; however, we lack knowledge on which cannabinoid(s) to use, dosing, and their pharmacological targets. |
2024-03-27 |
2024-03-29 |
Not clear |
| Orrin Devinsky, Nicholas A Jones, Mark O Cunningham, B Ashan P Jayaskera, Sasha Devore, Benjamin J Whalle. Cannabinoid treatments in epilepsy and seizure disorders. Physiological reviews. 2023-10-26. PMID:37882730. |
cannabinoid treatments in epilepsy and seizure disorders. |
2023-10-26 |
2023-11-08 |
Not clear |
| Orrin Devinsky, Nicholas A Jones, Mark O Cunningham, B Ashan P Jayaskera, Sasha Devore, Benjamin J Whalle. Cannabinoid treatments in epilepsy and seizure disorders. Physiological reviews. 2023-10-26. PMID:37882730. |
in the last few decades, preclinical animal studies and clinical investigations have established the role of cannabidiol (cbd) in treating epilepsy and seizures and support potential therapeutic benefits for cannabinoids in other neurological and psychiatric disorders. |
2023-10-26 |
2023-11-08 |
Not clear |
| Orrin Devinsky, Nicholas A Jones, Mark O Cunningham, B Ashan P Jayaskera, Sasha Devore, Benjamin J Whalle. Cannabinoid treatments in epilepsy and seizure disorders. Physiological reviews. 2023-10-26. PMID:37882730. |
here, we comprehensively review the role of cannabinoids in epilepsy. |
2023-10-26 |
2023-11-08 |
Not clear |
| Nicolás Fernández, Marcello Gian Cappello, Patricia Noemí Quirog. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina. Forensic science international. vol 349. 2023-07-01. PMID:37392612. |
in recent years, the therapeutic use of cannabis products, especially cannabis oils, has increased significantly, due to the pharmacological potential of their cannabinoids, for the treatment of conditions, such as pain management, cancer, and epilepsy. |
2023-07-01 |
2023-08-14 |
Not clear |
| Douglas da Silva Rodrigues, Adria Santos Bastos Soares, Claudia Dizioli Franco Buen. The use of cannabinoids in children with epilepsy: A systematic review. Epilepsy & behavior : E&B. vol 145. 2023-06-30. PMID:37390729. |
the use of cannabinoids in children with epilepsy: a systematic review. |
2023-06-30 |
2023-08-14 |
Not clear |
| Douglas da Silva Rodrigues, Adria Santos Bastos Soares, Claudia Dizioli Franco Buen. The use of cannabinoids in children with epilepsy: A systematic review. Epilepsy & behavior : E&B. vol 145. 2023-06-30. PMID:37390729. |
the aim of this paper was to evaluate the scientific evidence available in the literature regarding the use of cannabinoids in the therapy of children with epilepsy. |
2023-06-30 |
2023-08-14 |
Not clear |
| Daphna T Katz, Amanda Fifi, Alessandra Milesi-Halle, Miguel Sap. A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy. JPGN reports. vol 4. issue 1. 2023-05-15. PMID:37181918. |
a rare case of cannabinoid hyperemesis syndrome secondary to cannabidiol for refractory epilepsy. |
2023-05-15 |
2023-08-14 |
Not clear |
| Mauro Maccarrone, Vincenzo Di Marzo, Juerg Gertsch, Uwe Grether, Allyn C Howlett, Tian Hua, Alexandros Makriyannis, Daniele Piomelli, Natsuo Ueda, Mario van der Stel. Pharmacological reviews. 2023-05-10. PMID:37164640. |
compelling research evidence and the fda cannabis-derived cannabidiol approval for severe childhood epilepsy have confirmed the large therapeutic potential of cannabidiol itself, Δ9-tetrahydrocannabinol (thc) and other plant-derived cannabinoids (phytocannabinoids). |
2023-05-10 |
2023-08-14 |
human |
| Ali Al-Kaleel, Hatice Aygun, Lubna Al-Gailani, Yonca Kabak, Sinem Inal, Mustafa Ayyildiz, Aydin Him, Erdal Aga. The electrophysiological and behavioral evaluation of the peptide hemopressin and cannabinoid CB1 receptor agonist and antagonist in pentylenetetrazol model of epilepsy in rats. Pflugers Archiv : European journal of physiology. 2023-04-26. PMID:37100982. |
the electrophysiological and behavioral evaluation of the peptide hemopressin and cannabinoid cb1 receptor agonist and antagonist in pentylenetetrazol model of epilepsy in rats. |
2023-04-26 |
2023-08-14 |
rat |
| Thomas Harman, Michael Udoh, Dan L McElroy, Lyndsey L Anderson, Richard C Kevin, Samuel D Banister, Adam Ametovski, Jack Markham, Chris Bladen, Peter T Doohan, Quentin Greba, Robert B Laprairie, Terrance P Snutch, Iain S McGregor, John G Howland, Jonathon C Arnol. MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy. Frontiers in physiology. vol 14. 2023-04-21. PMID:37082241. |
mepirapim-derived synthetic cannabinoids inhibit t-type calcium channels with divergent effects on seizures in rodent models of epilepsy. |
2023-04-21 |
2023-08-14 |
Not clear |
| Leila Hosseinzadeh Anvar, Asghar Alejafar, Seyyed Ebrahim Moosavi, Saeid Charsouei, Narges Zeynalzadeh, Leila Mehdizadeh Fanid, Babak Emamalizadeh, Zahra Hassanpour Aydinlou, Helaleh Vaezi, Adel Kashefi, Carlos Tomaz, Masoud Nikanfar, Ali Ahmadalipou. The study of rs324420 (C385A) polymorphism of the FAAH gene of the endocannabinoid system in patients with epilepsy and ADHD. Epilepsy research. vol 192. 2023-04-05. PMID:37018974. |
the study of rs324420 (c385a) polymorphism of the faah gene of the endocannabinoid system in patients with epilepsy and adhd. |
2023-04-05 |
2023-08-14 |
human |
| D Kostic, M Nowakowska, J Freundt Revilla, F Attig, K Rohn, F Gualtieri, W Baumgärtner, H Potschka, A Tipol. Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy. Scientific reports. vol 13. issue 1. 2023-02-23. PMID:36823232. |
knowledge of its distribution in the epileptic brain would serve a better understanding of disease pathology and application of cannabinoids in dogs with epilepsy. |
2023-02-23 |
2023-08-14 |
Not clear |
| John S Markowitz, Ludmila De Faria, Qingchen Zhang, Philip W Melchert, Reginald F Frye, Brandon O Klee, Yuli Qia. The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects. Medical cannabis and cannabinoids. vol 5. issue 1. 2022-12-05. PMID:36467779. |
cannabidiol (cbd) is a widely utilized nonpsychoactive cannabinoid available as an over-the-counter supplement, a component of medical cannabis, and a prescriptive treatment of childhood epilepsies. |
2022-12-05 |
2023-08-14 |
human |
| Gian Marco Rosa, Luca Puce, Laura Mori, Antonio Currà, Francesco Fattapposta, Italo Porto, Nicola Luigi Bragazzi, Carlo Trompetto, Lucio Marinell. Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study. Frontiers in cardiovascular medicine. vol 9. 2022-11-17. PMID:36386386. |
cannabinoids may be useful to treat pain, epilepsy and spasticity, although they may bear an increased risk of cardiovascular events. |
2022-11-17 |
2023-08-14 |
Not clear |
| S Alisha Epp. Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy. Frontiers in psychiatry. vol 13. 2022-11-07. PMID:36339877. |
commonalities for comorbidity: overlapping features of the endocannabinoid system in depression and epilepsy. |
2022-11-07 |
2023-08-14 |
Not clear |
| S Alisha Epp. Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy. Frontiers in psychiatry. vol 13. 2022-11-07. PMID:36339877. |
the endocannabinoid system (ecs) of the brain has become an area of intense interest for possible roles in depression and epilepsy. |
2022-11-07 |
2023-08-14 |
Not clear |
| Heidrun Potschka, Sofie F M Bhatti, Andrea Tipold, Stephanie McGrat. Cannabidiol in canine epilepsy. Veterinary journal (London, England : 1997). 2022-10-09. PMID:36209995. |
moreover, social media and public pressure has sparked a renewed awareness of cannabinoids, which have been used for epilepsy since ancient times. |
2022-10-09 |
2023-08-14 |
human |